Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat
- PDF / 341,952 Bytes
- 1 Pages / 595.276 x 790.866 pts Page_size
- 33 Downloads / 166 Views
CORRECTION
Correction to: Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes Hitomi Komatsu1 · Mariko Enomoto1 · Hisashi Shiraishi1 · Yasuyo Morita1 · Daisuke Hashimoto2 · Shuichi Nakayama2 · Shogo Funakoshi2 · Seiki Hirano2 · Yoshio Terada2 · Mitsuhiko Miyamura1 · Shimpei Fujimoto2
© The Japan Diabetes Society 2020
Correction to: Diabetology International https://doi.org/10.1007/s13340-020-00434-w
In the original publication, the unit of C-peptide immunoreactivity (CPR) in Table 1 was published incorrectly. The correct unit is ng/ml. Publisher’s Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original article can be found online at https://doi.org/10.1007/ s13340-020-00434-w. * Shimpei Fujimoto fujimoto@kochi‑u.ac.jp 1
Department of Pharmacy, Kochi Medical School Hospital, Nankoku, Japan
Department of Endocrinology, Metabolism, and Nephrology, Kochi Medical School, Kochi University, Kohasu, Oko‑cho, Nankoku, Kochi 783‑8505, Japan
2
13
Vol.:(0123456789)
Data Loading...
